Exploring Levima Advanced Materials Corporation Investor Profile: Who’s Buying and Why?

CN | Basic Materials | Chemicals | SHZ

Levima Advanced Materials Corporation (003022.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Who's quietly steering Levima Advanced Materials (003022.SZ) and why are markets watching? With Legend Holdings controlling a commanding 51.77% stake and the Chinese Academy of Sciences Holdings holding a hefty 25.27%, Levima's ownership structure reads like a strategic alliance between corporate and research heavyweights - a backdrop that matters when the company's market capitalization of CNY 25.84 billion meets a 2024 revenue of CNY 6.27 billion and a striking 47.45% year‑on‑year plunge in net profit attributable to shareholders (CNY 234.44 million), while a trailing P/E of 87.12 as of November 28, 2025, signals lofty expectations as Levima pushes into new energy, biodegradable and electronic materials and executes moves like the August 2024 launch of Levima Ruisheng (Shandong) Special Materials Co., Ltd.-so who's buying, who's influencing strategy, and how might these stakes shape the next chapter for investors?

Levima Advanced Materials Corporation (003022.SZ) - Who Invests in Levima Advanced Materials Corporation (003022.SZ) and Why?

Institutional control and a mix of strategic, state-owned, private and asset-management investors shape Levima Advanced Materials Corporation's investor base. The shareholding structure reflects strategic alignment with large industrial groups and scientific institutions, targeted exposure by investment managers, and selective private capital participation.
  • Strategic majority holder: Legend Holdings Corporation's 51.77% stake (as of June 30, 2024) provides operational control and signals long-term strategic commitment to Levima's materials platform and downstream industrial integration.
  • State/science-backed investment: The Chinese Academy of Sciences Holdings Co., Ltd. owning 25.27% (as of December 31, 2024) indicates strong technology and R&D alignment, plus potential preferential access to scientific resources and collaborations.
  • Private/PE participation: Tengzhou Lianhongsheng Enterprise Management Partnership (LP) with 3.12% (as of December 31, 2024) represents targeted private-equity style exposure to Levima's growth in specialty materials.
  • Asset managers and institutional investors: Shenzhen Qianhai Huolan Asset Management Co., Ltd. (1.69%), China Southern Asset Management Co., Ltd. (0.45%), and Hong Kong Exchanges and Clearing Limited (0.34%) reflect diversified portfolio allocations and liquidity-provider or index-related positions.
Investor Ownership (%) Reporting Date Investor Type Likely Investment Rationale
Legend Holdings Corporation 51.77 June 30, 2024 Strategic/Controlling Control, industrial integration, long-term synergies with portfolio companies
Chinese Academy of Sciences Holdings Co., Ltd. 25.27 December 31, 2024 State-backed / R&D-oriented Technology collaboration, access to research, strategic alignment with national science goals
Tengzhou Lianhongsheng Enterprise Management Partnership (LP) 3.12 December 31, 2024 Private/PE Growth exposure, private capital participation in specialty materials growth
Shenzhen Qianhai Huolan Asset Management Co., Ltd. 1.69 December 31, 2024 Asset Manager Portfolio allocation, active asset management, potential alpha from sector exposure
China Southern Asset Management Co., Ltd. 0.45 December 31, 2024 Institutional Investor Minor strategic or index-related position, diversified institutional exposure
Hong Kong Exchanges and Clearing Limited 0.34 December 31, 2024 Market Infrastructure / Institutional Custodial/index-related, small strategic holding for market operations
  • Implications for governance: With Legend Holdings as majority shareholder and CAS Holdings as a large minority owner, governance decisions are likely driven by strategic-industrial and science-policy objectives rather than short-term market pressures.
  • Liquidity and market interest: Smaller stakes held by asset managers and market institutions provide tradable liquidity and reflect investor interest in the specialty materials sector's risk/return profile.
  • Partnership signals: The mix of state-backed and private investors suggests opportunities for technology commercialization, government-aligned projects, and private-capital-driven efficiency improvements.
Breaking Down Levima Advanced Materials Corporation Financial Health: Key Insights for Investors

Levima Advanced Materials Corporation (003022.SZ) Institutional Ownership and Major Shareholders of Levima Advanced Materials Corporation (003022.SZ)

Levima Advanced Materials Corporation's shareholder base is dominated by large strategic and institutional investors, with a clear controlling shareholder and several significant institutional and private stakes. Concentration of ownership affects governance, strategic direction, and liquidity for minority investors.
  • Largest shareholder: Legend Holdings Corporation - 51.77% (as of June 30, 2024), a controlling strategic investor providing operational and capital support.
  • Major institutional investor: Chinese Academy of Sciences Holdings Co., Ltd. - 25.27% (as of December 31, 2024), indicating strong state-linked backing and potential for technology/innovation collaboration.
  • Notable private/PE stake: Tengzhou Lianhongsheng Enterprise Management Partnership (LP) - 3.12% (as of December 31, 2024).
  • Asset manager participation: Shenzhen Qianhai Huolan Asset Management Co., Ltd. - 1.69% (as of December 31, 2024).
  • Smaller institutional stakes: China Southern Asset Management Co., Ltd. - 0.45%; Hong Kong Exchanges and Clearing Limited - 0.34% (both as of December 31, 2024).
Shareholder Equity Interest (%) As of Date Shareholder Type
Legend Holdings Corporation 51.77 June 30, 2024 Strategic / Controlling
Chinese Academy of Sciences Holdings Co., Ltd. 25.27 December 31, 2024 State-linked Institutional
Tengzhou Lianhongsheng Enterprise Management Partnership (LP) 3.12 December 31, 2024 Private / PE
Shenzhen Qianhai Huolan Asset Management Co., Ltd. 1.69 December 31, 2024 Asset Manager
China Southern Asset Management Co., Ltd. 0.45 December 31, 2024 Asset Manager
Hong Kong Exchanges and Clearing Limited 0.34 December 31, 2024 Exchange / Institutional
  • Implications for investors: high concentration under Legend Holdings (51.77%) implies strategic control, potential for aligned long-term R&D and capital allocation decisions, and limited free float relative to total shares outstanding.
  • Institutional support from Chinese Academy of Sciences Holdings (25.27%) suggests access to technology transfer and state-linked partnerships, often valued by long-term strategic investors.
  • Smaller holdings by asset managers and private partnerships indicate interest from both active and passive institutional strategies, but modest influence on governance given their sub-5% sizes.
Mission Statement, Vision, & Core Values (2026) of Levima Advanced Materials Corporation.

Levima Advanced Materials Corporation (003022.SZ) - Key Investors and Their Impact on Levima Advanced Materials Corporation

Levima Advanced Materials Corporation's shareholder base is concentrated, with a controlling majority holder and several strategic institutional investors whose stakes and profiles shape corporate strategy, R&D priorities, financing flexibility, and market access.
Investor Ownership (%) Reporting Date Primary Influence
Legend Holdings Corporation 51.77 June 30, 2024 Control over strategic direction, board appointments, capital allocation
Chinese Academy of Sciences Holdings Co., Ltd. 25.27 December 31, 2024 R&D collaboration potential, institutional credibility, technology partnerships
Tengzhou Lianhongsheng Enterprise Management Partnership (LP) 3.12 December 31, 2024 Private investment supporting innovation and growth projects
Shenzhen Qianhai Huolan Asset Management Co., Ltd. 1.69 December 31, 2024 Asset management expertise, potential channel for institutional capital
China Southern Asset Management Co., Ltd. 0.45 December 31, 2024 Institutional support and potential strategic fund partnerships
Hong Kong Exchanges and Clearing Limited 0.34 December 31, 2024 Market access, liquidity signaling, index-related flows
  • Majority control: Legend Holdings' 51.77% stake (6/30/2024) affords de facto control - ability to set long-term strategy, select board members, and approve material transactions.
  • Strategic institutional partner: Chinese Academy of Sciences Holdings' 25.27% (12/31/2024) strengthens Levima's R&D credibility and creates pathways for joint technology commercialization and access to national science networks.
  • Growth capital and innovation: Tengzhou Lianhongsheng (3.12%) and Shenzhen Qianhai Huolan (1.69%) represent private and asset-management capital that can be mobilized for capex, pilot projects, or minority co-investments.
  • Market and liquidity influences: China Southern AM (0.45%) and HKEX (0.34%) are small but meaningful for passive/active fund flows and index eligibility effects.
Ownership concentration metrics (illustrative impacts):
Metric Value / Implication
Top-2 combined ownership 77.04% - strong strategic alignment between a corporate investor and national science investor
Free float (approx.) ~22.96% - limited public float may increase volatility and reduce daily liquidity
Block holder influence High - major decisions likely coordinated by Legend + CAS Holdings
Implications for corporate decisions and capital markets behavior:
  • Governance: Board composition and executive appointments likely reflect Legend Holdings' strategic priorities, while CAS Holdings may secure R&D oversight roles or technical committees.
  • R&D and commercialization: CAS Holdings' presence increases probability of collaborative projects, government research grants, and accelerated product development cycles in advanced materials.
  • Financing strategy: With a dominant parent owner, Levima may prefer intra-group financing, strategic investments, or targeted minority raises rather than broad public equity issuances.
  • Market liquidity & valuation: Low free float magnifies the impact of block trades; institutional buying/selling by asset managers can move price more than in widely held peers.
Signaling to investors and counterparties:
  • Institutional credibility: CAS Holdings' significant stake signals technological depth and reduces perceived execution risk for R&D-heavy projects.
  • Strategic alignment: Legend's majority holding signals long-term industrial strategy rather than short-term market orientation, which can affect valuation multiples (e.g., premium for stability vs. discount for minority liquidity).
  • Potential for strategic M&A or joint ventures: High insider alignment increases probability of intra-group synergies, preferential supply agreements, or selective external partnerships.
Relevant link for company ethos and longer-term strategic framing: Mission Statement, Vision, & Core Values (2026) of Levima Advanced Materials Corporation.

Levima Advanced Materials Corporation (003022.SZ) - Market Impact and Investor Sentiment

Levima Advanced Materials Corporation (003022.SZ) occupies a notable market position with a market capitalization of CNY 25.84 billion as of November 28, 2025. Recent operating results and strategic moves have created a mixed investor narrative: growth-oriented initiatives in new energy and biodegradable materials contrast with shrinking revenue and profit that weigh on near-term sentiment.
  • Market capitalization (Nov 28, 2025): CNY 25.84 billion
  • Revenue (2024): CNY 6.27 billion, down 7.52% year-on-year
  • Net profit attributable to shareholders (2024): CNY 234.44 million, down 47.45% year-on-year
  • Trailing P/E (Nov 28, 2025): 87.12
Metric Value Period / Date YoY Change
Market Capitalization CNY 25.84 billion Nov 28, 2025 -
Revenue CNY 6.27 billion FY 2024 -7.52%
Net Profit (attributable) CNY 234.44 million FY 2024 -47.45%
Trailing P/E 87.12 Nov 28, 2025 -
Investor segment drivers and sensitivities:
  • Growth-seeking institutional investors attracted by strategic pivot into new energy materials, biodegradable materials, and electronic materials-areas with long-term demand potential.
  • Value-focused or risk-averse investors concerned by steep profit decline (47.45% YoY) and an elevated trailing P/E of 87.12, signaling high expectations or potential overvaluation.
  • Event-driven traders monitoring corporate actions and capacity expansion, notably the August 2024 establishment of Levima Ruisheng (Shandong) Special Materials Co., Ltd., which signals capex and geographic/segment diversification.
  • ESG- and sustainability-minded investors evaluating the shift toward biodegradable and new-energy materials as alignment with green investment themes.
Key quantitative indicators market participants reference when assessing Levima:
  • Profitability pressure: FY2024 net profit CNY 234.44M vs. prior year decline of 47.45%.
  • Revenue trajectory: CNY 6.27B in 2024, down 7.52% year-on-year-implication for margins and cash flow.
  • Valuation premium: Trailing P/E 87.12 suggests expectations of rapid earnings recovery or high-growth outlook priced in.
  • Market footprint: CNY 25.84B market cap provides liquidity and institutional access but invites benchmark comparisons with peers in advanced materials and specialty chemicals.
For strategic context and deeper corporate background, see: Levima Advanced Materials Corporation: History, Ownership, Mission, How It Works & Makes Money

DCF model

Levima Advanced Materials Corporation (003022.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.